BCA
TMO icon

Bay Colony Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bay Colony Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$614K Buy
1,224
+17
+1% +$8.16K 0.07% 231
2026
Q1 		$593K Sell
1,207
-15
-1% -$8.14K 0.07% 229
2025
Q4 		$708K Sell
1,222
-316
-21% -$179K 0.08% 211
2025
Q3 		$746K Sell
1,538
-34
-2% -$15.8K 0.09% 208
2025
Q2 		$637K Hold
1,572
– – 0.09% 204
2025
Q1 		$786K Sell
1,572
-36
-2% -$19.5K 0.12% 172
2024
Q4 		$837K Sell
1,608
-821
-34% -$451K 0.12% 169
2024
Q3 		$1.5M Buy
2,429
+20
+0.8% +$11.8K 0.23% 102
2024
Q2 		$1.33M Sell
2,409
-22
-0.9% -$12.6K 0.22% 94
2024
Q1 		$1.41M Buy
2,431
+323
+15% +$181K 0.25% 85
2023
Q4 		$1.12M Buy
2,108
+348
+20% +$168K 0.22% 100
2023
Q3 		$891K Buy
1,760
+301
+21% +$160K 0.21% 109
2023
Q2 		$761K Buy
1,459
+163
+13% +$88K 0.18% 119
2023
Q1 		$730K Buy
1,296
+39
+3% +$22K 0.19% 119
2022
Q4 		$692K Buy
1,257
+70
+6% +$37.1K 0.18% 133
2022
Q3 		$602K Sell
1,187
-20
-2% -$11.2K 0.18% 129
2022
Q2 		$722K Buy
1,207
+91
+8% +$50.1K 0.18% 126
2022
Q1 		$659K Buy
1,116
+190
+21% +$109K 0.16% 144
2021
Q4 		$618K Buy
926
+11
+1% +$6.87K 0.18% 141
2021
Q3 		$523K Buy
915
+13
+1% +$7.13K 0.17% 159
2021
Q2 		$455K Sell
902
-5
-0.6% -$2.36K 0.15% 183
2021
Q1 		$414K Buy
907
+40
+5% +$19.1K 0.16% 172
2020
Q4 		$404K Buy
867
+72
+9% +$33.8K 0.21% 143
2020
Q3 		$351K Buy
+795
New +$328K 0.22% 146
2018
Q3 		– Sell
-287
Closed -$59K – 828
2018
Q2 		$59K Buy
+287
New +$60.9K 0.04% 345

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bay Colony Advisors's TMO Position: Q2 2026 in Review

Bay Colony Advisors increased its Thermo Fisher Scientific (TMO) stake by 1.4% in Q2 2026, buying an estimated $8.16K and bringing the position to 1,224 shares worth $614K. The position accounts for 0.07% of the portfolio, ranked #231.

Bay Colony Advisors first reported a position in TMO in Q2 2018 and has held it in 25 quarters since. The position peaked at $1.5M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bay Colony Advisors held 1,224 shares of Thermo Fisher Scientific worth $614K as of Q2 2026.
  • Bay Colony Advisors bought 17 Thermo Fisher Scientific shares in Q2 2026, an estimated $8.16K.
  • Thermo Fisher Scientific made up 0.07% of Bay Colony Advisors's portfolio in Q2 2026, its #231 holding.
  • Bay Colony Advisors first reported a position in Thermo Fisher Scientific in Q2 2018 and has held it in 25 quarters since.
  • Bay Colony Advisors's Thermo Fisher Scientific position peaked at $1.5M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.